FIELD: medicine.
SUBSTANCE: present invention relates to immunology. Monoclonal antibody and its fragment are presented, which bind with K11-associated polyubiquitin, characterized by amino acid sequences of hypervariable sections (HVR). Isolated nucleic acid, which codes antibody, according to invention; expression vector; host cell and method of producing antibody are also described. Moreover, immunoconjugate and pharmaceutical composition for treating disease or disorder, containing antibody, according to invention; use of disclosed antibody for preparing drug; method of treating individual, suffering from disease or disorder, selected from cancer, degenerative muscle or nerve disorder; as well as method of determining presence of K11-associated polyubiquitin or polyubiquitinated protein; method of separating K11-associated polyubiquitinated protein and method of determining function and/or activity of K11-associated polyubiquitin are proposed.
EFFECT: present invention can find further application in therapy and diagnostics of diseases, associated with formation of polyubiquitins, containing bond, formed K11 lysine.
46 cl, 9 dwg, 5 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
ANTI-POLY-UBIQUITINATED ANTIBODIES AND METHODS OF APPLICATION | 2012 |
|
RU2630637C2 |
POLYSPECIFIC ANTIBODIES | 2009 |
|
RU2547596C2 |
ANTI-BV8 ANTIBODIES AND USING THEM | 2010 |
|
RU2559542C2 |
EXPRESSION AND SECRETION SYSTEM | 2013 |
|
RU2670491C2 |
ANTIBODIES TO JAGGED AND METHODS OF THEIR USE | 2013 |
|
RU2666990C2 |
ANTIBODIES AGAINST NOTCH2 AND METHODS FOR APPLICATION THEREOF | 2009 |
|
RU2580029C2 |
HUMANISED ANTI-FACTOR D ANTIBODIES AND APPLICATIONS THEREOF | 2012 |
|
RU2678802C2 |
HUMANISED ANTI-FACTOR D ANTIBODIES AND USE THEREOF | 2007 |
|
RU2474589C2 |
ANTIBODIES AGAINST NEYROPILIN AND METHODS OF THEIR APPLICATION | 2011 |
|
RU2571226C2 |
ANTI-TAT226 ANTIBODIES AND IMMUNOCONJUGATES | 2007 |
|
RU2448980C2 |
Authors
Dates
2016-11-20—Published
2011-04-14—Filed